Chongqing Lummy Pharmaceutical Co., Ltd. (SHE:300006)
China flag China · Delayed Price · Currency is CNY
5.09
-0.18 (-3.42%)
Aug 24, 2026, 3:04 PM CST

SHE:300006 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Revenue
748.94775.69795.6895.59884.591,225
Revenue Growth
-5.32%-2.50%-11.16%1.24%-27.80%-22.63%
Gross Profit
392.43420.37499.06612.44645.93844.3
Operating Income
-66.84-77.75-74.79-56.71-105.89-133.43
Net Income
-126.75-134.71-87.8-8.93-68.71-100.53
Earnings Per Share
-0.12-0.13-0.08-0.01-0.07-0.10
EPS Growth
------

Revenue by Segment

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Dec '21
Pharmaceutical Manufacturing
590.72668.99739.21753.61,051
Pharmaceutical Distribution
152.16103.92119.5893134.7
Service income
19.089.6315.4618.8624.72
Unallocated Other Operating Income
13.7313.0621.3419.1314.61
Total
775.69795.6895.59884.591,225

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Investments
1,085926.061,072836.44846.29559.43
Total Debt
493.48373.48494.59270.79365.27219.32
Net Cash (Debt)
591.22552.58577.51565.65481.02340.11
Net Cash Growth
5.44%-4.32%2.10%17.59%41.43%-
Net Cash Per Share
0.560.520.550.540.460.34

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Operating Cash Flow
50.5926.04185.0381.5357.13108.28
Capital Expenditures
-35.07-41.75-78.62-59.32-68.18-38.66
Free Cash Flow
15.52-15.71106.4122.21-11.0569.63
Free Cash Flow Growth
171.96%-379.04%---61.32%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Gross Margin
52.40%54.19%62.73%68.38%73.02%68.91%
Operating Margin
-8.92%-10.02%-9.40%-6.33%-11.97%-10.89%
Pretax Margin
-18.72%-18.93%-9.49%0.40%-8.51%-8.65%
Profit Margin
-16.92%-17.37%-11.04%-1.00%-7.77%-8.21%
FCF Margin
2.07%-2.02%13.37%2.48%-1.25%5.68%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Forward PE
-139.34139.34139.34139.34139.34
P/FCF Ratio
346.20-36.32176.84-103.43
PS Ratio
7.187.004.864.394.555.88